1
Drug Discovery Today Volume 16, Numbers 23/24 December 2011 POSTER ABSTRACTS method on the LabChip GXII for the analysis of low molecular weight proteins when inte- grated with the ready to use reagents not only simplifies the sample to answer paradigm but removes critical bottlenecks in the quality by the design of experiments. We describe the protocols for a robust protein assay and show quantitative analysis of EGF and VEGF illustrat- ing the resolution, the speed, and ease of use for high throughput screening in early stage development of biopharmaceuticals. doi:10.1016/j.drudis.2011.10.015 Poster 10 Innovative automated small scale par- allelized biochromatography for high throughput method development in downstream processing Tim Schroeder , Jürgen Friedle Atoll GmbH, Ettishofer Straße 10 D-88250 Weingarten, Germany A new platform technology has been devel- oped which enables 96 array format column chromatography. The design allows the user to select any chromatographic material that is packed with due consideration to individual material compression requirements. Bed con- tainment between two filter frits ensures high efficiency and peak symmetry similar to that of preparative and process separation columns, and distinguishes the system from the current filter based systems for simple on/off sample equilibration operation. Liquid flow in the columns was driven by positive pressure liquid displacement, like in columns individually connected to a one channel stand-alone chromatography system. Eight columns are operated in parallel and pre- programmed buffer preparation resulting in fast completion of 12 column rows. Fractions from step elution were col- lected into standard microplates, utilizing an automated microplate transport system and subsequently submitted to a next separation step for a further chromatographic dimen- sion or analysis like UV, ELISA, MS, HPLC or SDS-PAGE. This resulted in fully automated, walk-away procedures with a drastic reduction in process- ing time (up to 70%) and significantly increased process security. Applications shown were successfully implemented for parameter elucidation and optimization in process development of therapeutic protein production, in-process monitoring of fermentation broth for mAb- production, protein drug discovery and depletion of abundant components in screen- ing experiments. doi:10.1016/j.drudis.2011.10.016 Poster 11 High-throughput process development technology for design of cleaning-in-place (CIP) protocols for chromatography media Anna Grönberg , Hans J. Johansson, Kjell Eriksson, Enrique Carredano GE Healthcare Bio-Sciences AB, Björkgatan 30, 751 84 Uppsala, Sweden Cleaning-in-place (CIP) of chromatography media is important for the integrity and safety of the final biopharmaceutical product. Efficient and media compatible cleaning procedures also increase the column lifetime and thereby contribute to cost effective processes. We have developed a methodology where numerous cleaning agents and sequences of cleaning steps can be evaluated in parallel using PreDictor TM plates, i.e. 96-well filter plates pre-filled with chromatography media. The Pre- Dictor plates were cycled repeatedly with feed and the cleaning efficiency of a large number of different chemicals and sequences of cleaning steps were evaluated by analyzing the residual amount of proteins on the beads after cleaning. The throughput of the method was maximized by implementing the workflow on a robotic system and by using high-throughput analysis. The correlation between the scale-down screening format and traditional column life- time studies will be discussed. Process economy calculations comparing different resins and cleaning regimes will also be presented. doi:10.1016/j.drudis.2011.10.017 Poster 12 High throughput screening and optimiza- tion of intermediate wash conditions for a protein A chromatography step using a Design of Experiment (DoE) approach Kristina Nilsson-Välimaa , Gustav Rodrigo, Tuomo Frigård, Hans Johansson GE Healthcare Bio-Sciences AB, Björkgatan 30, 751 84 Uppsala, Sweden Purification of monoclonal antibodies using protein A affinity chromatography results in high purity and yield. By including an addi- tional intermediate wash step the purity of the product can increase even further. Here, optimal intermediate wash conditions were investigated using 96-well filter plates. Using a DoE approach in combination with a high throughput Host Cell Protein (HCP) analysis method, a large experimental space could be explored. Factors such as pH, type of salt, concentration and the effect of different additives were studied. Conditions that lead to significantly reduced HCP content in the prod- uct pool were identified quickly and effectively. Data obtained using the 96-well format was verified using a traditional column format with excellent correlation. The optimized condition was then further scaled up to a scale suitable for the production of material for toxicological studies. doi:10.1016/j.drudis.2011.10.018 www.drugdiscoverytoday.com 3 Poster abstracts

Innovative automated small scale parallelized biochromatography for high throughput method development in downstream processing

Embed Size (px)

Citation preview

Page 1: Innovative automated small scale parallelized biochromatography for high throughput method development in downstream processing

D De

m

o

g

s

r

t

p

q

i

f

d

d

PIatd

T

W

o

c

t

p

m

t

e

p

a

fi

e

p

i

c

E

p

f

l

a

for the production of material for toxicological

rug Discovery Today • Volume 16, Numbers 23/24 •

ethod on the LabChip GXII for the analysis

f low molecular weight proteins when inte-

rated with the ready to use reagents not only

implifies the sample to answer paradigm but

emoves critical bottlenecks in the quality by

he design of experiments. We describe the

rotocols for a robust protein assay and show

uantitative analysis of EGF and VEGF illustrat-

ng the resolution, the speed, and ease of use

or high throughput screening in early stage

evelopment of biopharmaceuticals.

oi:10.1016/j.drudis.2011.10.015

oster 10nnovative automated small scale par-llelized biochromatography for highhroughput method development inownstream processing

im Schroeder , Jürgen Friedle

Atoll GmbH, Ettishofer Straße 10 D-88250

eingarten, Germany

A new platform technology has been devel-

ped which enables 96 array format column

hromatography. The design allows the user

o select any chromatographic material that is

acked with due consideration to individual

aterial compression requirements. Bed con-

ainment between two filter frits ensures high

fficiency and peak symmetry similar to that of

reparative and process separation columns,

nd distinguishes the system from the current

lter based systems for simple on/off sample

quilibration operation.

Liquid flow in the columns was driven by

ositive pressure liquid displacement, like

n columns individually connected to a one

hannel stand-alone chromatography system.

ight columns are operated in parallel and pre-

rogrammed buffer preparation resulting in

ast completion of 12 column rows.

Fractions from step elution were col-

ected into standard microplates, utilizing

n automated microplate transport system and

cember 2011

subsequently submitted to a next separation

step for a further chromatographic dimen-

sion or analysis like UV, ELISA, MS, HPLC or

SDS-PAGE.

This resulted in fully automated, walk-away

procedures with a drastic reduction in process-

ing time (up to 70%) and significantly increased

process security.

Applications shown were successfully

implemented for parameter elucidation and

optimization in process development of

therapeutic protein production, in-process

monitoring of fermentation broth for mAb-

production, protein drug discovery and

depletion of abundant components in screen-

ing experiments.

doi:10.1016/j.drudis.2011.10.016

Poster 11High-throughput process developmenttechnology for design of cleaning-in-place(CIP) protocols for chromatography media

Anna Grönberg , Hans J. Johansson, Kjell

Eriksson, Enrique Carredano

GE Healthcare Bio-Sciences AB, Björkgatan 30,

751 84 Uppsala, Sweden

Cleaning-in-place (CIP) of chromatography

media is important for the integrity and safety

of the final biopharmaceutical product. Efficient

and media compatible cleaning procedures

also increase the column lifetime and thereby

contribute to cost effective processes.

We have developed a methodology where

numerous cleaning agents and sequences of

cleaning steps can be evaluated in parallel

using PreDictorTM plates, i.e. 96-well filter plates

pre-filled with chromatography media. The Pre-

Dictor plates were cycled repeatedly with feed

and the cleaning efficiency of a large number of

different chemicals and sequences of cleaning

steps were evaluated by analyzing the residual

amount of proteins on the beads after cleaning.

POSTER ABSTRACTS

The throughput of the method was maximized

by implementing the workflow on a robotic

system and by using high-throughput analysis.

The correlation between the scale-down

screening format and traditional column life-

time studies will be discussed. Process economy

calculations comparing different resins and

cleaning regimes will also be presented.

doi:10.1016/j.drudis.2011.10.017

Poster 12High throughput screening and optimiza-tion of intermediate wash conditions fora protein A chromatography step using aDesign of Experiment (DoE) approach

Kristina Nilsson-Välimaa , Gustav Rodrigo,

Tuomo Frigård, Hans Johansson

GE Healthcare Bio-Sciences AB, Björkgatan 30,

751 84 Uppsala, Sweden

Purification of monoclonal antibodies using

protein A affinity chromatography results in

high purity and yield. By including an addi-

tional intermediate wash step the purity of the

product can increase even further.

Here, optimal intermediate wash conditions

were investigated using 96-well filter plates.

Using a DoE approach in combination with

a high throughput Host Cell Protein (HCP)

analysis method, a large experimental space

could be explored. Factors such as pH, type of

salt, concentration and the effect of different

additives were studied. Conditions that lead to

significantly reduced HCP content in the prod-

uct pool were identified quickly and effectively.

Data obtained using the 96-well format was

verified using a traditional column format with

excellent correlation. The optimized condition

was then further scaled up to a scale suitable

studies.

doi:10.1016/j.drudis.2011.10.018

www.drugdiscoverytoday.com 3

• Posterabstracts